We at Merete GmbH are immensely proud and excited to announce the election of our owner and CEO, Alexia Anapliotis, to the board of BVMed. The BVMed, known fully as the German Medical Technology Association, plays a pivotal role in Germany’s healthcare industry. It represents the interests of over 230 member companies and actively works to shape the regulatory frameworks that drive innovation and quality in healthcare.

A Strong Mandate for the Future

Alexia Anapliotis election to the board is a testament to the high regard she holds within our industry and reflects the trust our colleagues place in her ability to lead and set directions. Her expertise will now contribute on a larger stage to influence the development of medical technology in Germany and beyond.

Thanks and Recognition

A heartfelt thank you goes to all members of the BVMed for their support and the trust they place in us. We also congratulate all other newly elected board members: Mark Jalaß (new Chairman), Dorothee Stamm (Vice Chairwoman), Marc Michel (Vice Chairman), Dr. Chima Abuba, Stefan Geiselbrechtinger, Manuela Hoffmann-Lücke, Frank Kirchner, and Dr. med Hans-Christian Wirtz. Collaborating with these experienced leaders will be crucial in tackling the challenges of our fast-paced industry.

Looking Forward: Innovation and Collaboration

The board election marks the beginning of an exciting phase of collaboration and innovation. We are thrilled about the opportunities that arise from close cooperation with other industry leaders and decision-makers. This dynamic partnership will enable us to not only influence but actively shape the landscape of medical technology.

Ready for the Future

We are ready to take on these challenges and look forward to working with Alexia Anapliotis at the helm and the entire BVMed board to shape the future of medical technology.

Back to Overview